By Scott Graham | July 15, 2019
Jan Weir and Kathrine Brandt of Weir & Brandt bring life science capabilities to the Los Angeles-based firm. Associate Stephen Underwood joins from Stroock.
By Xiumei Dong | July 15, 2019
Eric Rusnak and Ranjini Acharya have joined the New York-based firm's technology practice as partners in its Washington, D.C., and Palo Alto offices, respectively.
By Esha Bandyopadhyay and Kain Day | July 15, 2019
This article considers an area in which differing perspectives on the fundamental goal of trade secret damages may lead to differing damages methodologies: reasonable royalty damages.
By Scott Graham | July 11, 2019
RPX data shows a substantial drop in the success rate of Section 101 motions since the Federal Circuit tweaked patent eligibility law 18 months ago.
By Scott Graham | July 9, 2019
The wireless giant adds Goldstein & Russell to its team while arguing that Koh wrongly found it had an antitrust duty to deal with its rivals. Meanwhile, the FTC has consented to Qualcomm's request to expedite briefing on the merits.
By Scott Graham | July 8, 2019
The U.S. Court of Appeals for the Federal Circuit ordered the USPTO to reconsider an attack on the validity of two patents held by VirnetX, which holds two judgments worth almost $1 billion against the iPhone maker.
By Scott Graham | July 3, 2019
PTAB's increasing reluctance to hold trials on patent validity challenges is one possible factor on why filings could be down, experts say. Yet, Unified Patents is doing its part to keep the PTAB busy. It filed 28 petitions during the first half of the year, tied with Google for second most, behind only Apple Inc.
By Esha Bandyopadhyay and Kain Day | July 3, 2019
Whether damages should be directed at calculating the value of a trade secret or at calculating tangible losses incurred by the plaintiff is a fundamental issue tackled in a recent appellate decision out of New York.
By Scott Graham | July 1, 2019
The Washington, D.C.-based bar association sued the California-based Association of American Trial Lawyers for trademark infringement and unfair competition.
By Scott Graham | June 28, 2019
Fenwick lawyers persuade Colorado judge that without a drug in clinical trials, there's no rush to enjoin nine employees from continuing to work at Loxo Oncology Inc.
Presented by BigVoodoo
Celebrating California law firms and legal departments driving the state's dynamic legal landscape.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
AMENDED NOTICE OF BANKRUPTCY JUDGE VACANCIES DISTRICT OF UTAH The United States Court of Appeals for the Tenth Circuit seeks applicati...
The New Jersey State Commission of Investigation (SCI) is seeking an experienced and visionary leader to serve as its next Executive Directo...
We are a boutique firm specializing the area of real estate law and handling both litigation and transactional matters. We are seeking an as...